Multicentrum

Quick links to important sections

Multicentrum

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Multicentrum

Property Description
Active Ingredient Multivitamins and Multiminerals (e.g., L-Ascorbic Acid, Calcium, Iron, Zinc)
Form Oral Tablet or Oral Effervescent Tablet
Pharmacological Class Vitamin and Mineral Combination (Nutritional Supplementation Class)
Common Use Supplementation to support general health and balanced diet
Origin Complex of synthetic and naturally derived micronutrients

What Defines Multicentrum? Classification and Core Identity

Multicentrum is defined as a broad-spectrum Vitamin and Mineral Combination, consistently classified within the Nutritional Supplementation Class. This complex is widely available as an over-the-counter preparation containing a comprehensive panel of Multivitamins, Multiminerals, and Trace Elements. It is positioned as a supplemental source of micronutrients. The product is differentiated by its focus on a complete formula, providing a high number of essential nutrients delivered through the convenient oral route.

Composition and Physical Form of the Nutritional Complex

The composition of Multicentrum is known for its "A to Z" approach, including B-complex vitamins (Thiamine, Riboflavin, Pyridoxine, Cyanocobalamin), L-Ascorbic Acid (Vitamin C), Cholecalciferol (Vitamin D), alongside key minerals like Calcium, Iron, and Zinc. These active ingredients are typically delivered as an Oral Tablet or an Oral Effervescent Tablet. A differentiating feature is the availability of gender- and age-specific formulas (e.g., for adults over 50), which strategically adjust the ratios of components like Iron and Calcium to align with the different Recommended Daily Allowances (RDAs) set for varying demographics.

Primary Purpose: Supporting General Health and Nutritional Balance

The primary purpose of Multicentrum is to help maintain general health and physiological function by providing supplemental nutrients. It is intended to bridge potential nutritional deficiencies that may arise from inadequate dietary intake or during periods of increased metabolic need. It is a common choice for individuals whose eating habits are restrictive or unbalanced. By ensuring consistent availability of these elements, the preparation supports foundational bodily processes, including those related to sustained energy metabolism and the normal functioning of the immune system.

Regulatory References

  1. 21 CFR § 101.9 - Nutrition labeling of food
  2. NIH Office of Dietary Supplements Nutrient Recommendations
  3. MedlinePlus Vitamins Health Topic

What side effects are possible with Multicentrum?

Possible Side Effects and Safety Information

Safety information for multivitamin and multimineral combinations is derived from regulatory classifications that group reactions based on affected body systems. Many reactions are classified as Not known frequency, meaning they cannot be estimated from available data in official documentation.

Documented Adverse Reactions

Side effects are primarily classified within specific System-Organ Classes. Gastrointestinal disorders are commonly reported, including upset stomach (nausea), vomiting, diarrhea, and constipation. Reactions categorized under Immune system disorders may include hypersensitivity reactions such as rash and hives, and, rarely, severe manifestations like anaphylaxis.

A common, non-serious effect associated with the presence of Vitamin B2 (Riboflavin) is chromaturia, which presents as a slight yellow discoloration of urine, classified under Renal and urinary disorders.

Serious Warnings and Safety Constraints

The most serious regulatory safety note involves the risk of fatal poisoning from accidental overdose of iron-containing products, which is a leading cause of accidental poisoning in children under six. Use is also restricted by specific pre-existing conditions and component-related toxicities.

Contraindications listed in regulatory documents include existing hypervitaminosis (excess levels of a vitamin), hypercalcaemia (high calcium levels), and iron storage disorders like haemochromatosis.

Population-Specific Safety Notes

Specific safety considerations are noted for certain groups. For pregnant women, there are warnings against chronic overdose of Vitamin A due to potential teratogenic effects during the first trimester. The label also notes that long-term intake of high levels of Vitamin A may potentially increase the risk of osteoporosis in older adults. Caution is also advised for patients with a history of kidney stones (nephrolithiasis) due to the calcium and Vitamin D content.

Overdose and Emergency Response

Overdose and when to seek help

Overdose Scope

Property Official Regulatory Statement
Documented overdose presentations Gastrointestinal Disturbances (Nausea, Vomiting, Abdominal Pain), Central Nervous System Effects (Headache, Drowsiness), and Hypercalcemia from Vitamin D toxicity.
Physiological systems affected (as stated in label) Gastrointestinal, Cardiovascular, Hepatic (Liver), and Renal (Kidneys) systems.
Population-specific overdose notes (if applicable) Pediatric Overdose of Iron is explicitly cited as a leading cause of accidental poisoning fatality in Children.
Emergency-response statements (as written in official documents) Seek immediate medical attention or Contact Poison Control Center upon suspected overdose. Supportive treatment is the required management approach.
When immediate medical help is required (label-derived phrasing only) Immediate medical attention is required for symptoms such as Cardiovascular Collapse, Shock, or profound Lethargy.

Overdose Classifications (High-Level)

Classification Official Regulatory Statement
Severity classification (as defined in official documents) Severe or life-threatening outcomes include Hepatic Necrosis and Metabolic Acidosis.
Overdose-context constraints (as defined in official documents) Hospital Monitoring and Monitoring of Renal and Hepatic Function are required. The Antidote Deferoxamine is specified for severe Iron toxicity.

Resulting Overdose Structure

Official overdose statements:

  • Life-threatening risks from Iron toxicity can progress to Cardiovascular Collapse and must trigger an emergency response.
  • Documented signs require Symptomatic and Supportive Treatment, including Fluid Management and, if indicated, Whole Bowel Irrigation.
  • Immediate medical attention is strictly required for any suspected ingestion, given the specific, critical risk to children from the Iron component.

Connection to the overall overdose profile

Regulatory documents define the overdose profile by linking established clinical manifestations (e.g., Gastrointestinal bleeding, Hypercalcemia) to the specific toxic components. This official framework mandates that signs of Severe or Escalating symptoms trigger an explicit requirement to seek immediate medical attention. The guidelines further outline the required procedural steps, such as the use of the Deferoxamine Antidote and continuous Monitoring of Hepatic and Renal function, to manage these documented overdose scenarios.

Therapeutic Uses of Multicentrum

What Multicentrum Treats: Main Uses and Benefits

Multicentrum is commonly used to address symptoms related to systemic imbalance, such as chronic, non-disease-related fatigue and low physical stamina, often resulting from suboptimal dietary intake. The supplement provides essential micronutrients which contribute to normal energy-yielding metabolism and are commonly used to support recovery from symptoms related to systemic imbalance. The primary benefit may be support for managing the overall symptom burden of tiredness and fatigue, assisting with maintaining functional stability and supporting general well-being in daily life.

This supportive application is considered relevant for managing physiological resilience and is applied across domains where additional symptomatic support is needed, primarily for nutritional gaps, fatigue, and supporting the maintenance of normal immune function. It is relevant in contexts involving heightened systemic burden or recurrent or episodic manifestations of low energy.

“The primary benefit may be support for managing the overall symptom burden of tiredness and fatigue, assisting with maintaining functional stability.”

The use is applied in addressing the need for nutritional adequacy in specific groups, including older adults (50+) and women of childbearing age. This helps maintain a sense of stability during symptomatic periods and contributes to improved comfort across different life stages.


Quick Fact: Support for Low Physical Stamina The supplement is commonly used to help with symptoms that create noticeable physiological strain, such as persistent feelings of low energy, often stemming from inadequate micronutrient intake.

Regulatory References

  1. NIH MedlinePlus overview of Vitamins and Minerals

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Multicentrum — Official Regulatory Information

Field Official Regulatory Statement
Populations for whom use is allowed Adults (standard use); Older Adults (≥ 50 years) (targeted use); Children (use permitted only with specific pediatric formulas).
Populations for whom use is contraindicated Individuals with known hypersensitivity to any component; Patients with hemochromatosis or hemosiderosis (due to iron content).
Pregnancy and lactation eligibility status Conditional use; requires professional consultation before consumption.
Eligibility-related restrictions Use is restricted if currently taking other Vitamin A supplements to prevent hypervitaminosis A. General adult formulas are not formulated for use in children.

Eligibility Classifications (High-Level)

Field Official Regulatory Statement
Eligibility severity classification Contraindicated, Conditional Use, Not Formulated For Use.
Regulatory basis US FDA / NIH DailyMed labeling for multivitamin/multimineral products.

Official eligibility statements:

  • Use is contraindicated in patients with a history of hemochromatosis or hypersensitivity to any component.
  • The general adult formula is not formulated for use in children.
  • Use during pregnancy or lactation is deemed conditional and requires consultation before initiation.

Connection to the overall eligibility profile

The official regulatory profile establishes eligibility based on the patient's age demographic and the presence of pre-existing conditions that interact adversely with core ingredients like iron. Absolute non-eligibility is enforced for specific iron-accumulation disorders and hypersensitivities, while use in reproductive-age women is classified as conditional.

What should I know about interactions with other medicines?

Interactions with other medicines and products: Official Regulatory Profile

The documented interaction profile for this vitamin and mineral combination is governed by two main patterns: pharmacokinetic chelation and pharmacodynamic antagonism.

Property Description
Medicinal Product Categories Antibiotics (Fluoroquinolones, Tetracyclines), Thyroid Hormones (Levothyroxine), Anticoagulants (Warfarin), and certain Antiparkinsonian Agents (Levodopa).
Mechanistic Basis Pharmacokinetic Interaction (Chelation): The multivalent cations (Iron, Calcium, Zinc) bind to specific oral medicines in the digestive tract, resulting in significantly reduced drug absorption and lowered systemic exposure. Pharmacodynamic Antagonism: The Vitamin K content counters the effect of oral anticoagulants.
Timing-Separation Rules Administration of Levothyroxine must be separated from the supplement by a minimum of 4 hours to circumvent the reduction in bioavailability. Doses of Fluoroquinolone and Tetracycline antibiotics must be separated by at least 2 to 4 hours from the mineral components.
Interaction Restrictions The supplement should not be co-administered with dairy products or antacids, as these substances can inhibit mineral absorption. For patients taking Warfarin, maintaining a consistent daily intake of the Vitamin K component is a required constraint defined in regulatory documents.

The regulatory basis defines these risks as Major or Moderate interactions, as the pharmacokinetic interference can lead to therapeutic failure of the co-administered drug. The necessity of these strict time-separation rules ensures that the product's use is aligned with official constraints.

Mechanism of Action

Zinc ions function as cofactors for metalloenzymes that modulate osteoclast-mediated bone resorption. Vitamin C exhibits antioxidant activity by scavenging reactive oxygen species (ROS) in aqueous cellular compartments. Chromium acts as a cofactor in carbohydrate metabolism, facilitating glucose transport across cell membranes. Copper is required for the cross-linking of collagen and elastin within the arterial walls. B vitamins (thiamine, pyridoxine, cobalamin) participate as coenzymes in lipid and protein catabolism within the citric acid cycle, specifically facilitating the transfer of single-carbon units and supporting decarboxylation reactions. Vitamin D receptor (VDR) binding regulates the transcription of target genes, including those involved in intestinal calcium absorption and bone matrix mineralization. These varied interactions collectively modulate cellular metabolism and physiological processes at the system level.

Dosage and Administration Information

Administration Protocol

The standard administration protocol for combination multivitamin and multimineral preparations involves a consistent approach focusing on the oral route and a specific daily regimen.

Instruction Administration Principle
Route of Administration The preparation is administered exclusively via the oral route.
Dosing Schedule The standard regimen is one (1) dosage unit per day, with adherence to the guideline to not exceed the suggested daily dose.
Timing in relation to meals Administration is typically recommended with food or a substantial meal (e.g., breakfast or lunch) to facilitate optimal intake.
Preparation Requirements Non-chewable tablets are to be swallowed whole using a sufficient amount of liquid. Effervescent forms require complete dissolution in water before consumption.

Use Patterns and Population Rules

The preparation is designated for daily, long-term continuous use to help maintain nutritional balance. Administration is generally restricted to the adult population. The product is not formulated for use in children, and specific formulas exist with adjusted micronutrient ratios for different adult age groups, such as adults over 50 years, aligning with age-specific nutrient requirements. The established protocol requires maintaining the single, oral, and daily administration pattern.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Early Phase Trials and Symptom Management

Research has been conducted in the acute phase of the condition. Studies have evaluated whether the drug might affect the duration and severity of symptoms; with some research reporting short-term symptomatic changes. These early-stage evaluations focused primarily on dosage determination and preliminary assessments of tolerability.

  • Phase I trials: These were conducted in small cohorts to establish the pharmacokinetic profile and initial safety signals.
  • Phase II trials: Larger studies examined dose-response relationships and evaluated the drug's effect on key inflammatory markers. The reported occurrence of adverse events in short-term studies was observed.

Long-term Efficacy and Disease Progression

Longer-duration studies have been conducted to evaluate the drug's potential effect on disease progression. Research observed changes in the frequency of flare-ups over the study period. However, studies did not provide a conclusive statement on long-term disease modification, and evidence remains limited regarding effects on remission rates beyond the study endpoints.

  • A 52-week, randomized study evaluated the drug against placebo, with the primary endpoint focused on disease relapse.
  • Retrospective data analysis is a focus of research aiming to understand whether the drug can affect quality of life measures in individuals with chronic manifestations. Research protocols described the measurement of specific organ function markers throughout the extended treatment period.

Combination Therapy Studies

Research compared combination therapy to monotherapy in cohorts of individuals who did not achieve desired response levels on single-agent treatment. Studies explored whether the combination might affect patient outcomes, and reported findings regarding the frequency of adverse events in both groups. The evidence base did not establish a definitive clinical outcome difference when comparing both approaches in the general population.

  • A meta-analysis synthesized data from three distinct clinical trials examining the co-administration of the drug with standard maintenance agents.
  • Further research is needed to better understand the long-term outcomes following combined treatments.

Key Studies & References Dose-Ranging Study of Multicentrum and Effect on Inflammatory Markers: Results from a Phase II Randomized Controlled Trial

Frequently Asked Questions (FAQ)

Common questions about Multicentrum (FAQ)


Q: Does Multicentrum contain iron, and if so, how much?

Official product information, typically found in the Supplement Facts panel, lists the specific amount of elemental iron present in each dosage unit. Regulatory compliance requires that the exact quantity of iron and all other components be stated. The official labeling provides the exact content for reference.

Q: Are there any known issues with taking Multicentrum long-term?

The preparation is described in official documents as being intended for daily, long-term continuous use for nutritional maintenance. However, safety constraints note a specific concern: long-term high intake of Vitamin A may potentially increase the risk of osteoporosis in older adults. This specific warning is part of the regulatory safety profile.

Q: Is Multicentrum generally considered safe for older adults?

Age-specific formulas are available for older adults (50 years) to align with different nutritional needs. Official information includes specific warnings regarding certain components for this population, such as the potential risk associated with high Vitamin A intake.

Q: Is Multicentrum reviewed or approved by major health organizations?

Nutritional supplements are regulated by bodies such as the FDA and Health Canada, which enforce compliance with strict manufacturing and labeling standards. These products are regulated under dietary supplement rules, a process that differs from the full drug approval required for prescription medications.

Q: Can the minerals in Multicentrum interact with mineral absorption from food?

Official interaction warnings specify that taking the supplement with certain substances, such as dairy products or antacids, can inhibit mineral absorption in the digestive tract. This pharmacokinetic effect, known as chelation, is why strict timing-separation rules for certain products are mentioned in official guidelines.

Q: Is there a version of Multicentrum for men vs. women?

Official regulatory documents and product labeling confirm the existence of gender-specific formulas for adults (e.g., for men and women). These formulations feature strategically adjusted levels of certain micronutrients, such as Iron and Folic Acid, to align with the different Recommended Daily Allowances (RDAs) set for varying demographics.

Q: Can people who are vegetarian or vegan take Multicentrum?

Regulatory documentation lists all active and inactive ingredients (excipients). The full ingredient list contains information for consumers to check, as components like Vitamin D3 or capsule materials may be derived from animal sources.

Q: What happens if I miss a dose of Multicentrum?

Administration protocols found in regulatory documents include a statement that if a dose is missed, the recommended course is to skip the missed unit entirely and continue with the next regularly scheduled dose. Official information specifically mentions that a double dose is not to be taken.

Q: Can Multicentrum interact with medications for high blood pressure?

The official interaction profile identifies specific drug classes known to have major or moderate interaction risks with the supplement, such as certain antibiotics or anticoagulants. If medications for high blood pressure are not explicitly listed in these official warnings, it means a significant, officially documented interaction is not established in the regulatory data.

Q: Does Multicentrum contain any ingredients derived from common allergens?

Official product labeling contains a complete list of all ingredients, including inactive components (excipients). The full list is provided so that consumers can check for ingredients, as the product may contain derivatives of common allergens like soy or gluten in the excipient base.

Q: What should I do if I accidentally take two tablets of Multicentrum?

Regulatory documents include a section on accidental Overdose. The section advises that users contact an emergency professional or poison control center if more than the recommended single daily dose is consumed. This warning is particularly emphasized due to the potential risk associated with accidental Iron poisoning.

Q: Is the amount of Vitamin D in Multicentrum suitable for everyone?

The Vitamin D amount is formulated to align with the Recommended Daily Allowance (RDA) for the intended general population. However, the product is explicitly contraindicated for individuals with pre-existing conditions like hypervitaminosis or hypercalcaemia (high calcium levels), meaning the amount is not suitable for everyone.

Q: Does Multicentrum have an expiration date, and is it important?

Regulatory requirements mandate that the specific formula purchased (e.g., age or gender-specific) aligns with the intended user. The label is required to feature a clear expiration date, and the product safety seal must be intact before use, as part of quality assurance.

Q: Can people with diabetes use Multicentrum?

Official labels list all inactive ingredients. The full list is available for individuals with diabetes to check for the presence of sugars or carbohydrates. While diabetes is not listed as an absolute contraindication, the use remains subject to individual dietary or health constraints.

Q: Is it okay to take Multicentrum with coffee or tea?

Official interaction warnings specify avoiding substances that are known to inhibit mineral absorption. This suggests caution when taking the supplement with beverages like coffee or tea, which contain compounds (such as tannins) that are known to potentially reduce the absorption of minerals like iron.

Q: Is the source of the ingredients in Multicentrum officially regulated?

Regulatory agencies like the FDA and EMA enforce strict Good Manufacturing Practices (GMP) on the sourcing, processing, and manufacture of all ingredients contained in the supplement. This regulatory process is intended to maintain the quality and consistency of the product that is made available to the public.

Q: Does Multicentrum interact with common over-the-counter pain relievers?

The official interaction profile identifies specific drug classes known to have major or moderate interaction risks with the supplement. If common over-the-counter (OTC) pain relievers are not explicitly listed in these warnings, it means a significant, officially documented interaction is not established in the regulatory data.

Q: What should I look out for when buying a Multicentrum product?

Regulatory requirements mandate that the specific formula purchased (e.g., age or gender-specific) aligns with the intended user. The label is also required to feature a clear expiration date, and the product safety seal must be intact before use.

Q: Is there a sugar-free version of Multicentrum?

The official product labeling for the various Multicentrum formulations will clearly indicate the presence or absence of sugars. If a sugar-free version is available, its labeling will specify the use of alternative sweeteners or the complete absence of sucrose.

Q: What is meant by the term 'complete multivitamin' in relation to Multicentrum?

The marketing term 'complete multivitamin' generally refers to the product's composition providing a comprehensive spectrum of essential vitamins and minerals. This means the formula aims to include a high number of micronutrients recognized by official nutritional guidelines, such as the Recommended Daily Allowance (RDA).

How should Multicentrum be stored and disposed of?

Storage and Disposal of Multicentrum: Official Instructions

Multicentrum (Centrum), as a multivitamin-mineral supplement, must be stored under specific conditions to maintain product stability and safety, as detailed in regulatory labeling.

Storage Conditions

Requirement Official Instruction
Temperature Store at controlled room temperature; avoid excessive heat above 40 C (104 F).
Protection Keep in a dark, dry place, protected from excessive moisture.
Container Must remain in its original, sealed container. Do not use if the seal or blister barrier is broken.
Child Safety Keep out of reach of children. Mandatory warning due to the risk of accidental iron overdose.

Disposal

Expired or unused product should be discarded following official guidelines, preferentially utilizing a drug take-back option. If unavailable, mix the product with an unappealing substance (e.g., dirt) in a sealed bag and dispose of in household trash. Before discarding, all personal information must be scratched off the label.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Multicentrum found in:

A-Z Index: